Search Ontology:
ChEBI
(S)-timolol (anhydrous)
- Term ID
- CHEBI:9599
- Synonyms
-
- (-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
- (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- (S)-1-(1,1-(dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- (S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
- (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol
- (S)-timolol
- 1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol
- S-(-)-3-(3-tert-butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
- Timolol
- Definition
- The (S)-(−) (more active) enantiomer of timolol. A beta-adrenergic antagonist, both the hemihydrate and the maleate salt are used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine.
- References
-
- cas:26839-75-8
- drugbank:DB00373
- drugcentral:4061
- kegg.compound:C07141
- kegg.drug:D08600
- lincs.smallmolecule:LSM-2176
- patent:DE1925956
- patent:DE2915955
- patent:US3655663
- patent:US3657237
- pdb-ccd:TIM
- pubmed:10891117
- pubmed:11300874
- pubmed:11728183
- pubmed:11784135
- pubmed:14971904
- pubmed:15027870
- pubmed:15857133
- pubmed:1635066
- pubmed:2002467
- pubmed:2579237
- pubmed:2872332
- pubmed:2892933
- pubmed:2903243
- pubmed:6094812
- pubmed:6109024
- pubmed:6113285
- pubmed:6126588
- pubmed:6134834
- pubmed:8568799
- pubmed:9288160
- reaxys:1084707
- wikipedia.en:Timolol
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from (S)-timolol (anhydrous)
Phenotype where environments contain (S)-timolol (anhydrous)
Phenotype modified by environments containing (S)-timolol (anhydrous)
Phenotype affecting (S)-timolol (anhydrous)
Human Disease Model